Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 51655-539

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 51655-539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 539 20 Master Bottle Label Approval Rev A 01 21)

Label (51655 539 20 Master Bottle Label Approval Rev A 01 21)
This is a description of Cyclobenzaprine Hydrochloride Tablets, a medication with NDC number 51655-539-20. It is a prescription drug and the dosage information should be found in the package insert. The tablets are packaged in containers with 20 tablets, and it is recommended to be stored at a controlled room temperature, between 20° - 25°C (68° - 77°F). The container should be kept tightly closed and out of the reach of children. The tablet is made by Northwind Pharmaceuticals, and each coating contains Cyclobenzaprine hydrochloride. The medication has a lot number of 0000000000 and an expiration date of 00/00/0000. This medication was repackaged by TruPhama, LLC from the manufacturer labeled bottle 52817-332-00.*
FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Image (Cyclobenzaprine HCl Tabs Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.